TK
Insider buying
Thomas K Equels bought $5K of AIM stock
Thomas K Equels, CEO & President of AIM ImmunoTech Inc. (AIM), bought 31,675 shares of AIM stock worth $5K, per an SEC Form 4 filed Oct 26, 2026.
It was an open-market purchase.
The trade happened on Oct 23, 2026, 3 days before it was made public.
AIM has moved +0.0% since the trade date, from $0.16 to $0.16 (Oct 23, 2026 close).
- Traded
- Oct 23, 2026
- Disclosed
- Oct 26, 2026
- Filing delay
- 3 days
- Price since
- +0.0%
- Role
- CEO & President
- Source
- SEC Form 4
More AIM insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.